Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis.
Oomen I, Camelo RM, Rezende SM, Voorberg J, Mancuso ME, Oldenburg J, Carcao M, Matino D, Lillicrap D, Fischer K, Fijnvandraat K, Gouw SC; International Genetic and clinical determinants of the Outcome of Immune Tolerance Induction (GO-ITI) study group. Oomen I, et al. Among authors: rezende sm. Res Pract Thromb Haemost. 2022 Dec 20;7(1):100020. doi: 10.1016/j.rpth.2022.100020. eCollection 2023 Jan. Res Pract Thromb Haemost. 2022. PMID: 36891524 Free PMC article.
Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab.
Camelo RM, Barbosa MM, Araújo MS, Muniz RL Jr, Guerra AA Jr, Godman B, Rezende SM, Acurcio FA, Martin AP, Alvares-Teodoro J. Camelo RM, et al. Among authors: rezende sm. Value Health Reg Issues. 2023 Mar;34:31-39. doi: 10.1016/j.vhri.2022.10.007. Epub 2022 Dec 1. Value Health Reg Issues. 2023. PMID: 36463835 Free article.
Prevalence of sporadic haemophilia A.
Santana MAP, Chaves DG, Camelo RM, Zuccherato LW, Jardim LL, Rezende SM; in behalf of the HEMFIL and BrazIT Study Groups*. Santana MAP, et al. Among authors: rezende sm. Haemophilia. 2023 Mar;29(2):668-670. doi: 10.1111/hae.14742. Epub 2023 Jan 27. Haemophilia. 2023. PMID: 36706366 No abstract available.
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation.
Barnes GD, Ageno W, Castellucci LA, Chiasakul T, Eslick R, Ferreiro JL, Gailani D, Gorog DA, Lip GYH, Raffini L, Rezende SM, Weitz JI, Cuker A. Barnes GD, et al. Among authors: rezende sm. J Thromb Haemost. 2023 May;21(5):1381-1384. doi: 10.1016/j.jtha.2023.02.008. Epub 2023 Feb 14. J Thromb Haemost. 2023. PMID: 36796485 Free PMC article.
Barriers in the diagnosis of pulmonary embolism.
Rezende SM. Rezende SM. Lancet Haematol. 2023 Jan;10(1):e11. doi: 10.1016/S2352-3026(22)00359-3. Lancet Haematol. 2023. PMID: 36566044 No abstract available.
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America.
Neumann I, Izcovich A, Aguilar R, Basantes GL, Casais P, Colorio CC, Guillermo Esposito MC, García Lázaro PP, Pereira J, Meillon García LA, Rezende SM, Serrano JC, Tejerina Valle ML, Altuna D, Zúñiga P, Vera F, Karzulovic L, Schünemann HJ. Neumann I, et al. Among authors: rezende sm. Blood Adv. 2023 Jul 11;7(13):3005-3021. doi: 10.1182/bloodadvances.2021006534. Blood Adv. 2023. PMID: 36929813 Free PMC article.
Prediction of inhibitor development in previously untreated and minimally treated children with severe and moderately-severe hemophilia A using a machine-learning network.
Jardim LL, Schieber TA, Santana MP, Cerqueira MH, Lorenzato CS, Brognoli Franco VK, Zuccherato LW, Santos BADS, Chaves DG, Ravetti MG, Rezende SM. Jardim LL, et al. Among authors: rezende sm. J Thromb Haemost. 2024 May 27:S1538-7836(24)00303-9. doi: 10.1016/j.jtha.2024.05.017. Online ahead of print. J Thromb Haemost. 2024. PMID: 38810700
Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice.
Cuker A, Kunkle R, Bercovitz RS, Byrne MT, Djulbegovic B, Haberichter SL, Holter-Chakrabarty J, Lottenberg R, Pai M, Rezende SM, Seftel MD, Silverstein RL, Terrell DR, Cheung MC. Cuker A, et al. Among authors: rezende sm. Blood Adv. 2024 Apr 9:bloodadvances.2023011102. doi: 10.1182/bloodadvances.2023011102. Online ahead of print. Blood Adv. 2024. PMID: 38593461
136 results